Point72 Hong Kong’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,900
Closed -$1.4M 370
2022
Q3
$1.4M Buy
7,900
+1,200
+18% +$237K 0.05% 459
2022
Q2
$1.37M Buy
6,700
+6,100
+1,017% +$1.29M 0.05% 445
2022
Q1
$143K Buy
+600
New +$141K ﹤0.01% 1061
2021
Q4
Sell
-13,000
Closed -$2.51M 1960
2021
Q3
$2.51M Buy
13,000
+3,800
+41% +$770K 0.08% 357
2021
Q2
$1.96M Sell
9,200
-14,800
-62% -$3.12M 0.06% 435
2021
Q1
$4.9M Buy
24,000
+16,900
+238% +$3.33M 0.17% 122
2020
Q4
$1.29M Buy
+7,100
New +$1.21M 0.06% 393

Other funds holding CME

Point72 Hong Kong's CME Position: Q3 2025 in Review

Point72 Hong Kong sold out of CME Group (CME) in Q3 2025, closing a stake of 75,370 shares — an estimated $20.8M sold.

Point72 Hong Kong first reported a position in CME in Q2 2016 and held it in 23 quarters. The position peaked at $20.8M in Q2 2025. 1,651 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Point72 Hong Kong reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 75,370 CME Group shares in Q3 2025, an estimated $20.8M.
  • Point72 Hong Kong first reported a position in CME Group in Q2 2016 and held it in 23 quarters.
  • Point72 Hong Kong's CME Group position peaked at $20.8M in Q2 2025.
  • 1,651 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.